Precision Bio director granted 20,979 RSUs
Buehler Kevin reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Buehler Kevin reported acquisition or exercise transactions in this Form 4 filing.
PRECISION BIOSCIENCES INC director Kevin Buehler received a grant of 20,979 Restricted Stock Units (RSUs), each representing a contingent right to one share of common stock. These RSUs vest on the earlier of June 3, 2027, or the day immediately before the company’s next annual stockholder meeting, subject to his continued service. Following this compensation-related award, Buehler holds 20,979 RSUs directly.
Insider Trade Summary
Grant/Award: 20,979 shares
Grant/Award
1 txn
Insider
Buehler Kevin
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 20,979 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Units — 20,979 contracts (Direct)
Footnotes (2)
- F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- F2. The RSUs vest on the earlier to occur of (i) June 3, 2027 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.
Key Figures
RSUs granted: 20,979 units
RSU to share ratio: 1 RSU : 1 share
Post-grant RSU holdings: 20,979 units
+1 more
4 metrics
RSUs granted
20,979 units
Restricted Stock Units granted to director on June 3, 2026
RSU to share ratio
1 RSU : 1 share
Each RSU represents one share of common stock
Post-grant RSU holdings
20,979 units
Total RSUs held by Kevin Buehler after the grant
Latest vesting date
June 3, 2027
Latest possible vesting date for the RSUs, subject to service
Key Terms
Restricted Stock Units, contingent right, vest, annual meeting of stockholders
4 terms
Restricted Stock Units financial
"The security is described as Restricted Stock Units with underlying common stock."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
contingent right financial
"Each RSU represents a contingent right to receive one share of Common Stock."
vest financial
"The RSUs vest on the earlier of June 3, 2027, or before the next annual meeting."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
annual meeting of stockholders financial
"Vesting may occur the day immediately prior to the next annual meeting of stockholders."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did PRECISION BIOSCIENCES (DTIL) report for Kevin Buehler?
PRECISION BIOSCIENCES reported that director Kevin Buehler received 20,979 Restricted Stock Units. Each RSU is a contingent right to one share of common stock, representing a compensation-related equity award rather than an open-market stock purchase or sale.
How many Restricted Stock Units did Kevin Buehler receive from PRECISION BIOSCIENCES (DTIL)?
Kevin Buehler received 20,979 Restricted Stock Units from PRECISION BIOSCIENCES. These RSUs give him the right to receive an equal number of common shares if vesting conditions are met, aligning his compensation with the company’s share performance over time.
When do Kevin Buehler’s RSUs at PRECISION BIOSCIENCES (DTIL) vest?
The RSUs vest on the earlier of June 3, 2027, or the day immediately before the next annual stockholder meeting. Vesting also requires Kevin Buehler to continue serving the company through the applicable vesting date, tying the award to ongoing board service.
Is Kevin Buehler’s Form 4 transaction in DTIL an open-market trade?
No, the Form 4 transaction reflects a grant of 20,979 Restricted Stock Units as compensation. It is coded as a grant or award, not an open-market purchase or sale, so it does not represent a discretionary buy or sell of existing Precision BioSciences shares.
How many RSUs does Kevin Buehler hold in PRECISION BIOSCIENCES (DTIL) after this grant?
After the reported grant, Kevin Buehler holds 20,979 Restricted Stock Units. These RSUs are settled in common stock if the vesting conditions are satisfied, so they represent potential future ownership rather than currently issued and outstanding common shares.
AI-generated analysis. How Rhea-AI works. Not financial advice.
